Clinical and attentional effects of acute nicotine treatment in Tourette's syndrome

European Psychiatry

Volumn 19, Issue 2, 2004, Pages 102-112

  Howson, Anne L ^a   Batth, Sue ^b   Ilivitsky, Vadim ^b   Boisjoli, Armand ^c   Jaworski, Martine ^c   Mahoney, Colleen ^b   Knott, Verner J ^b  

^a VANCOUVER GENERAL HOSPITAL   (Canada)

^b ROYAL OTTAWA HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Attention; Event related potentials; Nicotine; Performance; Tics; Tourette's syndrome

Indexed keywords

AMFEBUTAMONE; CLONIDINE; DEXAMPHETAMINE; HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; PAROXETINE; PIMOZIDE; PLACEBO; RISPERIDONE; TRAZODONE;

ADOLESCENT; ARTICLE; ATTENTION; ATTENTION DEFICIT DISORDER; BREATHING DISORDER; CHILD BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENT RELATED POTENTIAL; FEMALE; GILLES DE LA TOURETTE SYNDROME; HEART PALPITATION; HUMAN; MALE; MUSCLE CRAMP; MUSCLE WEAKNESS; NAUSEA; PAIN; PARENT; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; SELF REPORT; SYNCOPE; THORAX PAIN; TINNITUS; TRANSDERMAL PATCH; TREATMENT FAILURE; TREATMENT OUTCOME; VOMITING;

EID: 1642506238     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2003.11.002     Document Type: Short Survey

References (54)

1. Achenbach T.M. Manual for child behaviour checklist and revised child behaviour profile. 1983;Department of Psychiatry, University of Vermont, Burlington, VT.
2. Barkley R.A. Attention-deficit hyperactivity disorder: a handbook for diagnosis and treatment. 1990;Guilford Press, New York.
3. Channon S., Flynn D., Robertson M.M. Attentional deficits in Gilles de la Tourette syndrome. Neuropsychiatry Neuropsychol Behav Neurol. 5:1992;170-177.
4. Cohen D.J., Detlor J., Young J.G., Shaywitz B.A. Clonidine ameliorates Gilles de la Tourette syndrome. Arch Gen Psychiatry. 37:1980;1350-1357.
5. Conners C.K. Conners' rating scales manual. 1991;Multi-Health Systems Inc, Toronto.
6. Devor E.J., Isenberg K.E. Nicotine and Tourette's syndrome [letter]. J Neuropsychiatry Clin Neurosci. 5:1993;108-109.
7. Dimitsopoulos T., Kurlan R. Tourette's syndrome and nicotine withdrawal [letter]. J Neuropsychiatry Clin Neurosci. 5:1993;108-109.
8. Drake M.E., Heitter S.A., Padamadan H., Bogner J.E., Andrews J.M., Weate S. Auditory evoked potentials in Gilles de la Tourette syndrome. Clin Electroencephalogr. 23:1992;19-23.
9. Dursun S.M., Reveley M.A. Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome. Br J Clin Pharmacol. 30:1995;1008-1018.
10. Dursun S.M., Reveley M.A. The efficacy of a dose-escalated application of transdermal nicotine plus sulpiride in Tourette's syndrome. Eur Psychiatry. 11:1996;204-206.
11. Dursun S.M., Reveley M.A. Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study. Psychol Med. 27:1997;48.
12. Dursun S.M., Reveley M.A., Bird R., Stirton F. Long-lasting improvement of Tourette's syndrome with transdermal nicotine. Lancet. 344:1994;1577.
13. Emerich D.F., Norman A.B., Sanberg P.R. Nicotine potentiates the behavioral effects of haloperidol. Psychopharmacol Bull. 27:1991;385-390.
14. Emerich D.F., Zanol M.D., Norman A.B., McConville B.J., Sanberg P.R. Nicotine potentiates haloperidol-induced catalepsy and locomotor hypoactivity. Pharmacol Biochem Behav. 38:1991;875-880.
15. Erenberg G., Cruse R.P., Rothner A.D. Tourette syndrome: an analysis of 200 pediatric and adolescent cases. Clevel Clin Q. 53:1986;127-131.
16. Escera C., Alho K., Schröger E., Winkler I. Involuntary attention and distractibility as evaluated with event-related brain potentials. Audiol Neuro-Otol. 5:2000;151-166.
17. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., Russell M.A.H. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology. 127:1996;31-38.
18. Jagger J., Prusoff B.A., Cohen D.J., et al. The epidemiology of Tourette's syndrome: a pilot study. Schizophr Bull. 8:1982;267-278.
19. Klorman R. Cognitive event-related potentials in attention deficit disorder. J Learning Dis. 24:1996;130-140.
20. Knott V., Bosman M., Mahoney C. Transdermal nicotine: single dose effects on mood, EEG, performance and event-related potentials. Pharmacol Biochem Behav. 63:1993;253-261.
21. Leckman J.F., Peterson B.S., Anderson G.M., et al. Pathogenesis of Tourette's syndrome. J Clin Psychol Psychiatry. 38:1997;119-142.
22. Leckman J.F., Riddle M.A., Hardin M.T., Ort S.I., Swartz K.L., Stevenson J., et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 28:1997;566-573.
23. Leckman J.F., Towbin K.E., Ort S.I., Cohen D.J. Clinical assessment of tic disorder severity. Cohen D.J., Bruun R.D., Leckman J.F. Tourette's syndrome and tic disorders: clinical understanding and treatment. 1988;6-28 Wiley, New York.
24. Le Houezec J., Halliday R., Benowitz N.L., Callaway E., Naylor H., Herzig K. A low dose of subcutaneous nicotine improves information processing in non-smokers. Psychopharmacology. 114:1994;628-634.
25. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
26. Levin E.D., Wilson W., Rose J.E., McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacol. 15:1996;429-436.
27. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology. 123:1996;55-63.
28. McConville B.J., Fogelson M.H., Norman A.B., Klykylo W.M., Manderscheid P.Z., Parker K.W., et al. Nicotine potentiation of haloperidol in reducing tic frequency in Tourette's disorder. Am J Psychiatry. 148:1991;793-794. Correction 1991;148:1282.
29. McConville B.J., Sanberg P.R., Fogelson M.H., King J., Cirino P., Parker K.W., et al. The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder. Biol Psychiatry. 31:1992;832-840.
30. Moss D.E., Manderscheid P.Z., Kobayashi P.Z., Montgomery S.P. Evidence for the nicotine cholinergic hypothesis of cannabinoid action within the central nervous system: extrapyramidal behaviors. Chesher G., Consroe P., Musty R. Marijuana: an international research report, Monograph Series No. 7. 1988;359-364 Australian Government Publishing Service, Canberra, Australia.
31. Moss D.E., Manderscheid P.Z., Montgomery S.P., Norman A.B., Sanberg P.R. Nicotine and cannabinoids as adjuncts to neuroleptics in the treatment of Tourette syndrome and other motor disorders. Life Sci. 44:1989;1521-1525.
32. Nestor P.G., Faux S.F., McCarley R.W., Shenton M.E., Sands S.F. Measurement of visual sustained attention in schizophrenia using signal detection analysis and a newly developed computerized CPT task. Schizophr Res. 3:1990;329-332.
33. Nuechterlein K.H., Parasuraman R., Qiyuan J. Visual sustained attention: image degradation produces rapid sensitivity decrement over time. Science. 220:1983;327-329.
34. Cohen J. Statistical power analysis for the behavioral sciences. 1977;New York Academic Press, New York.
35. Pritchard W., Robinson J. Effects of nicotine on human performance. Snel J., Lorist M. Nicotine, caffeine and social drinking: behavior and brain function. 1998;21-81 Harwood Academic Press, Amsterdam.
36. Randolph C., Hyde T.M., Gold J.M., Goldberg T.E., Weinberger D.R. Tourette's syndrome in monozygotic twins: relationship of tic severity to neuropsychological function. Arch Neurol. 50:1993;725-728.
37. Robertson M.M. Annotation: Gilles de la Tourette syndrome - an update. J Child Psychol Psychiatry. 35:1994;597-611.
38. Sahakian B.J., Jones G., Levy R., Gray J., Warburton D.M. The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry. 154:1989;797-800.
39. Sanberg P.R., Fogelson H.M., Mandersheid P.Z., Parker K.W., Norman A.B., McConville B.J. Nicotine gum and haloperidol in Tourette's syndrome. Lancet. 12:1988;592.
40. Sanberg P.R., McConville B.J., Fogelson H.M., Manderscheid P.Z., Parker K.W., Blythe M.M., et al. Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome. Biomed Pharmacother. 43:1989;19-23.
41. Sand P. neuropsychological test performance before and after symptom removal in a child with Gilles de la Tourette syndrome. J Clin Psychol. 28:1972;596-600.
42. Shucard D.W., Benedict R.H.B., Tekok-Kilic A., Lichter D.G. Slowed reaction time during a continuous performance test in children with Tourette's syndrome. Neuropsychology. 11:1997;147-155.
43. Shuerholz L.J., Baumgardner T.L., Singer H.S., Reiss A.L., Denckla M.B. Neuropsychological status of children with Tourette's syndrome with and without attention deficit hyperactivity disorder. Neurology. 46:1998;958-965.
44. Shytle R.D., Silver A.A., Philipp M.K., et al. Transdermal nicotine for Tourette's syndrome. Drug Dev Res. 35:1996;1631-1636.
45. Silver A.A., Sanberg P.R. Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet. 342:1993;182.
46. Silver A.A., Shytle R.D., Philipp M.K., Sanberg P.R. Transdermal nicotine in Tourette's syndrome. Clarke P.B.S., Quik M., Thurau K., Aldkofer F. Effects of nicotine on biological systems II: advances in pharmacological sciences. 1995;293-299 Birkhauser Verlag, Basel.
47. Silver A.A., Shytle R.D., Phillip M.K., Sanberg P.R. Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 35:1996;1631-1636.
48. Silver A.A., Shytle R.D., Philipp M.K., Wilkinson B.J., McConville B., Sanberg P.R. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study. J Clin Psychiatry. 62:2001;707-714.
49. Silverstein S.M., Como P.G., Palumbo D.R., West L.L., Osborn L.M. Multiple sources of attentional dysfunction in adults with Tourette syndrome: comparison with attention deficit-hyperactivity disorder. Neuropsychology. 9:1995;157-164.
50. Strandburg R.J., Marsh J.T., Brown W.S., Asarnow R.F., Higa J., Harper R., et al. Continuous-processing-related event-related potentials in children with attention deficit hyperactivity disorder. Biol Psychiatry. 40:1996;964-980.
51. Van Woerkom T.C.A.M., Fortgens C., Rompel-Martens C.M.C., Van de Wetering B.J.M. Auditory event-related potentials in adult patients with Gilles de la Tourette's syndrome in the oddball paradigm. Electroencephalogr Clin Neurophysiol. 71:1988;443-449.
52. Wechsler D. Manual for the Wechsler Intelligence Scale for Children - Revised. 1981;The Psychological Corporation, New York.
53. Yeates K., Bornstein R. Attention deficit disorder and neuropsychological functioning in children with Tourette's syndrome. Neuropsychology. 8:1994;65-74.
54. Wechsler D. Manual for the Wechsler Intelligence Scale for children. 1993;The Psycholological Corporation, New York.